Department of Ophthalmology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Medicine (Baltimore). 2022 Jul 22;101(29):e29637. doi: 10.1097/MD.0000000000029637.
Primary vitreoretinal lymphoma is a great masquerader and provides a diagnostic challenge.It is most frequently misdiagnosed as a chronic uveitis. Steroid treatment for presumed uveitis can interfere with the correct diagnosis of vitreoretinal lymphoma. Herein, we present a case of primary vitreoretinal lymphoma in which the correct diagnosis was delayed by short-term steroids until 2 years later.
A 45-year-old woman presented with floaters and blurred vision in her right eye for 3 months. An ocular examination revealed dense vitreous cells. Three months later, she developed headache and suicidal ideation after taking a 3-week medication of oral steroid medication from another eye clinic. Brain magnetic resonance imaging revealed a tumor involving the corpus callosum and periventricular region.
Vitreous biopsy and repeated brain biopsies were carried out for the patient.
A brain biopsy was performed for the first time, and a vitreous biopsy was performed when steroid medication was suspended for 20 and 41 days, respectively. Both biopsies were negative for the presence of malignant cells. Follow-up magnetic resonance imaging revealed complete remission of the brain tumor. Two years later, the tumor recurred in the optic chiasm. Diffuse large B-cell lymphoma was confirmed by a second brain biopsy.
The patient had complete tumor remission after receiving brain radiation therapy and chemotherapy.
Vitreoretinal lymphoma is difficult to diagnose owing to its rarity, masquerading presentation, and steroid-induced apoptosis of lymphoma cells. Physicians should consider vitreoretinal lymphoma as an important differential diagnosis in patients presenting with chronic uveitis and use steroids cautiously before making a definitive diagnosis.
原发性眼内淋巴瘤是一种极具伪装性的疾病,诊断极具挑战性。它最常被误诊为慢性葡萄膜炎。为疑似葡萄膜炎而进行的类固醇治疗可能会干扰对眼内淋巴瘤的正确诊断。在此,我们报告了一例原发性眼内淋巴瘤病例,由于短期使用类固醇,直到 2 年后才做出正确诊断。
一名 45 岁女性因右眼出现漂浮物和视力模糊 3 个月就诊。眼部检查显示玻璃体细胞密集。3 个月后,她在另一家眼科诊所接受了 3 周的口服类固醇治疗后出现头痛和自杀意念。脑部磁共振成像显示肿瘤累及胼胝体和脑室周围区域。
对患者进行了玻璃体活检和多次脑部活检。
首次进行了脑部活检,当类固醇药物治疗暂停 20 天和 41 天时,分别进行了玻璃体活检。两次活检均未发现恶性细胞。随访磁共振成像显示脑部肿瘤完全缓解。两年后,肿瘤在视交叉处复发。第二次脑部活检证实为弥漫性大 B 细胞淋巴瘤。
患者接受脑部放射治疗和化疗后完全缓解肿瘤。
由于其罕见性、伪装性表现和类固醇诱导的淋巴瘤细胞凋亡,眼内淋巴瘤的诊断较为困难。医生在做出明确诊断之前,应将眼内淋巴瘤视为慢性葡萄膜炎患者的重要鉴别诊断,并谨慎使用类固醇。